Background
Harmen is a PhD candidate at the Division of Imaging and Oncology at the University Medical Centre Utrecht. His research focuses on palliative and multidisciplinary treatments, as well as improving the quality of life for patients with spinal metastases. He serves as the coordinator of the BLEND trial, for which he conducts a health technology assessment (HTA) to evaluate the cost-effectiveness and budget impact. Prior to his current role, Harmen conducted research at Massachusetts General Hospital and Harvard Medical School within the Skeletal Oncology Research Group (SORG). His work there focused on developing predictive models for survival and quality of life in patients with spinal metastases.

In addition to his research, Harmen is in the final year of medical school. He holds a Bachelor’s degree in Mathematics from Utrecht University and has specialized training in applied biostatistics and machine learning for predictive modeling.

Projects

• PRESENT+
• BLEND

Most recent publications

Keywords: Spinal Metastases | Palliative Treatment | Applied Biostatistics | Machine Learning for Predictive Modeling

Social media and other resources
Email: r.h.kuijten-2@umcutrecht.nl | ORCiD | ResearchGate | LinkedIn